Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. The company also has an agreement with MDxHealth SA for collaboration in the field of epigenetics and molecular diagnostics. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
